| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | Chief Financial Officer | Chief Financial Officer
2 companies
Glenn John is a Chief Financial Officer at EKSO, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 6 sales. Those positions are worth an estimated $1.2M at current prices.
Our model assigns Glenn John a below-average insider score of 43/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -10.6%.
Glenn John's largest disclosed position is in IRMD as CFO, worth about $1.1M. The recent filings there lean toward selling, a net 28,151 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | IRMD Iradimed Corp | Chief Financial Officer | Sale+OE | 15,000 | $97.29 | $1,459,341.56 | -67.1% | +3.5% | - | |
| Nov 10, 2025 | IRMD Iradimed Corp | Chief Financial Officer | Sell | 10,651 | $84.51 | $900,161.81 | -81.0% | +11.5% | - | |
| Dec 2, 2024 | IRMD Iradimed Corp | Chief Financial Officer | Sell | 2,500 | $54.18 | $135,449.25 | -36.3% | -1.0% | +71.0% | |
| Mar 22, 2022 | EKSO Ekso Bionics Holdings, Inc. | Chief Financial Officer | Sell | 3,462 | $2.82 | $9,761.80 | -9.0% | -39.6% | -49.8% | |
| May 31, 2019 | EKSO Ekso Bionics Holdings, Inc. | Chief Financial Officer | Sell | 10,292 | $1.37 | $14,100.04 | -68.6% | - | - |